ArticleDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft2012
[Spectral domain OCT in central serous chorioretinopathy: description of retinal changes].
Article in Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 7 citations in OpenAlex.
- Proportion and risk factors of retinal changes in pregnant women with HELLP syndrome.BMC pregnancy and childbirth · 2026Article
- [Central serous chorioretinopathy].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2021Review
- [Mineralocorticoid receptor antagonists as treatment option for acute and chronic central serous chorioretinopathy].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2014Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim was to describe the morphological alterations of the retina seen in spectral domain optical coherence tomography (SD-OCT) of eyes with central serous chorioretinopathy (CSC). PATIENTS AND
methodsData of patients in the database with CSC examined with SD-OCT scans (n = 50) and fluorescein angiography (FA) were analyzed for representative cases exhibiting significant changes of the retinal structure allowing a direct comparison of SD-OCT with FA images and a description of the findings.
resultsApart from the 3 well-known CCS types [type I shows only subretinal fluid (SRF), type II only serous pigment epithelial detachment (PED) and the intermediate type showing both SRF and PED] hybrid forms were also observed in multifocal CSC, for example type I and type II next to each other. Of the patients 1 showed transformation from type II to type I over a period of 3 months. Small bulges of the retinal pigment epithelium (RPE) seen in OCT images could be angiographically related to leakage spots. Degenerative changes with subretinal granular sediments, patchy defects in the photoreceptor layer, granular alterations of the RPE and atrophy of the RPE and neuroretina were particularly observed in chronic CSC.
conclusionSpectral domain OCT is a valuable imaging technology enabling detailed visualization of retinal changes in patients with CSC. It gives access to a better understanding of the disease mechanisms and may provide a new approach to the classification and understanding of CSC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.